![Anjali Ganguli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anjali Ganguli
Corporate Officer/Principal en SYNDAX PHARMACEUTICALS, INC. .
Cargos activos de Anjali Ganguli
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SYNDAX PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2015 | - |
Historial de carrera de Anjali Ganguli
Antiguos cargos conocidos de Anjali Ganguli.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Regado Biosciences, Inc.
![]() Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/02/2014 | 01/05/2015 |
Formación de Anjali Ganguli.
University of Michigan | Doctorate Degree |
The University of Chicago | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Regado Biosciences, Inc.
![]() Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Anjali Ganguli
- Experiencia